This article is a correction to:
Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
Ana Copaescu1*
Phuti Choshi2
Sarah Pedretti3
Effie Mouhtouris1
Jonathan Peter2,3
Jason A. Trubiano1,4,5,6- 1Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia
- 2Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa
- 3Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa
- 4Department of Oncology, Sir Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia
- 5Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia
- 6The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
A Corrigendum on
Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
by Copaescu, A., Choshi, P., Pedretti, S., Mouhtouris, E., Peter, J., and Trubiano, J. A. (2021). Front. Pharmacol. 12:640012. doi: 10.3389/fphar.2021.640012
In the original article, we mistakenly omitted a statement from the Funding section. The statement reads as follows: “JP receives financial support from National Institutes of Health, award K43TW011178-02; the EDCTP2 programme supported by the European Union, grant number TMA2017SF-1981 and the South African National Research Foundation (NRF). PC receives a PhD fellowship from the Fogarty HATTP program, funded by the National Institutes of Health, award D43 TW010559-01”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: delayed hypersensitivity reaction, drug allergy, severe cutaneous adverse reaction, t-cell, enzyme link immunospot, cytotoxicity, flow cytoametry, lactate dehydrogenase
Citation: Copaescu A, Choshi P, Pedretti S, Mouhtouris E, Peter J and Trubiano JA (2021) Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics. Front. Pharmacol. 12:758192. doi: 10.3389/fphar.2021.758192
Received: 13 August 2021; Accepted: 18 August 2021;
Published: 02 September 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Copaescu, Choshi, Pedretti, Mouhtouris, Peter and Trubiano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ana Copaescu, ana.copaescu@gmail.com